000 | 01279 a2200361 4500 | ||
---|---|---|---|
005 | 20250514000315.0 | ||
264 | 0 | _c20010830 | |
008 | 200108s 0 0 eng d | ||
022 | _a0378-6501 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoublevskaia, I N | |
245 | 0 | 0 |
_aBcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest. _h[electronic resource] |
260 |
_bDrugs under experimental and clinical research _c2000 |
||
300 |
_a149-56 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlkaloids _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBerberine Alkaloids |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
650 | 0 | 4 |
_aMitosis _xdrug effects |
650 | 0 | 4 | _aPhenanthridines |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis |
700 | 1 | _aHaake, A R | |
700 | 1 | _aPolevoda, B V | |
773 | 0 |
_tDrugs under experimental and clinical research _gvol. 26 _gno. 5-6 _gp. 149-56 |
|
999 |
_c11277731 _d11277731 |